12900 Results (Page 258 of 516)
All Market Research Reports
Indonesia Alcohol Addiction Therapeutics Market Analysis
The Indonesia Alcohol Addiction Therapeutics Market is valued at around $4 Mn in 2022 and is projected to reach $7 Mn by 2030, exhibiting a CAGR of 6.3% during the forecast period. Increasing awareness campaigns, reduced stigma, expanding healthcare infrastructure, and a changing social landscape, drive the potential demand for addiction treatment services, especially among youth in Indonesia. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Indonesia are Elli Lily, Lundbeck, AstraZeneca, Indivior, Alkermes, TEVA Pharmaceuticals, Merck & Co., Kimia Farma, Kalbe Farma and Osotspa among others
Germany Alcohol Addiction Therapeutics Market Analysis
The Germany Alcohol Addiction Therapeutics Market is valued at around $26 Mn in 2022 and is projected to reach $37 Mn by 2030, exhibiting a CAGR of 4.5% during the forecast period. The major growth drivers of the Germany alcohol addiction therapeutics market include increased public knowledge through media campaigns and advocacy activities, the development of newer and more individualized therapies, particularly medication-assisted therapy (MAT), and the surge in government spending on addiction treatment. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Germany are Elli Lily, Roche, AbbVie, Lundbeck, Otsuka Pharmaceuticals, Hexal, Stada, Viatris, and Berlin-Chemie, among various others
France Alcohol Addiction Therapeutics Market Analysis
The France Alcohol Addiction Therapeutics Market is valued at around $20 Mn in 2022 and is projected to reach $30 Mn by 2030, exhibiting a CAGR of 5.3% during the forecast period. The increasing public awareness of alcoholism, a rising number of cases, and growing government support, including healthcare financing and preventive laws, indicate a shifting societal attitude towards alcohol addiction in France. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in France are Elli Lily, Roche, AbbVie, Lundbeck, Otsuka Pharmaceuticals, Servier, Ipsen, Viatris, and Bioprojet, among various others
Egypt Alcohol Addiction Therapeutics Market Analysis
The Egypt Alcohol Addiction Therapeutics Market is valued at around $2 Mn in 2022 and is projected to reach $4 Mn by 2030, exhibiting a CAGR of 7.8% during the forecast period. The market growth in the country is fueled by the changing societal attitudes, increased middle-class discretionary incomes and the increased government’s efforts to improve healthcare facilities. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Egypt are Alkermes, Teva Pharmaceuticals, Addex Therapeutics, Opiant Pharmaceuticals, GlaxoSmithKline (GSK), Merck & Co., Pharos Holding, Egypharm, Amoun Pharmaceuticals, Egyptian International Pharmaceutical Marketing Co. (EIPMCO) etc among others.
US Cancer Immunotherapy Market Analysis
US's cancer immunotherapy market is projected to grow from $47.3 Bn in 2022 to $70.4 Bn by 2030, registering a CAGR of 5.1% during the forecast period of 2022-30. Cancer is a leading cause of death worldwide, and its prevalence is increasing due to factors such as an aging population and changing lifestyles. This has led to a growing demand for effective cancer treatments, including immunotherapies. Key players in the market include Bristol-Myers Squibb, Merck & Co., Inc., Novartis International AG, Roche Holding AG, AstraZeneca plc, Amgen Inc., and others.
Canada Age-Related Macular Degeneration Therapeutics Market Analysis
The Canada Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $0.86 Bn in 2022, and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to US $1.71 Bn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, advancements in diagnostic technologies, and other factors. The industry is primarily dominated by players such as Genentech, Novartis, Bayer, Roche, and Ocular Therapeutics, among others
US Artificial Intelligence (AI) in Healthcare Market Analysis
US Artificial Intelligence (AI) in the healthcare market is projected to grow from $2.9 Bn in 2022 to $51.3 Bn by 2030, registering a CAGR of 43.22% during the forecast period of 2022-30. The US Artificial Intelligence (AI) in the Healthcare market is a rapidly growing industry that involves the use of AI technologies to improve patient care, reduce costs, and increase efficiency in healthcare delivery. IBM Watson Health offers a range of AI-powered healthcare solutions, including clinical decision support, medical image analysis, and patient monitoring.
US Alexipharmic Drugs Market Analysis
US Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 2.70% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The US Alexipharmic Drugs market will grow because of the rising prevalence of various forms of chronic conditions and overdosing on prescription medications. The key market players are Pfizer Inc. (USA), Bristol-Myers Squibb Company (USA), Mylan N.V. (USA), and others.
UK Oncology Clinical Trials Market Analysis
UK oncology clinical trials market is projected to grow from $328.9 Mn in 2022 to $433.1 Mn by 2030, registering a CAGR of 3.50% during the forecast period of 2022-30. The market will be driven by the rising incidence of cancer in the UK and efforts to promote research, collaboration, and innovation. The market is segmented by phase, study design, and indication. Some of the major players include Novartis AG, AstraZeneca & Astex Pharmaceuticals.
UK Obesity Drugs Market Analysis
This report presents a strategic analysis of the UK Obesity Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the UK Obesity Drugs Market, offering unmatched value, accuracy, and expert insights.
UK Medical Devices Market Analysis
This report presents a strategic analysis of the UK Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the UK Medical Devices Market, offering unmatched value, accuracy, and expert insights.
UK In Vitro Fertilisation (IVF) Service Market Analysis
This report presents a strategic analysis of the UK In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the UK In Vitro Fertilisation (IVF) Service Market, offering unmatched value, accuracy, and expert insights.
UK Healthcare Reimbursement Market Analysis
This report presents a strategic analysis of the UK Healthcare Reimbursement Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the UK Healthcare Reimbursement Market, offering unmatched value, accuracy, and expert insights.
UK Healthcare Insurance Market Analysis
UK's healthcare insurance market is projected to grow from $52.68 Bn in 2022 to $81.46 Bn by 2030, registering a CAGR of 5.6% during the forecast period of 2022-30. The main factors driving the growth would be the rising cost of medical services, the increasing number of daycare procedures, and government initiatives. The market is segmented by component, provider, coverage, health insurance plans, and end-user. Some of the major players include Bupa, Aviva, VitalityHealth, Simplyhealth and Saga.
UK ENT Devices Market Analysis
UK ENT Devices Market is projected to grow from $600 Mn in 2022 to $810 Mn by 2030, registering a CAGR of 3.8% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. Some of the key players in the UK ENT devices market include Otomagnetics, Keystone ENT, and AventaMed.
UK Coronary Stents Market Analysis
UK's Coronary Stents Market is expected to witness growth from $294 Mn in 2022 to $365 Mn in 2030 with a CAGR of 2.75% for the forecasted year 2022-30. In the UK, coronary artery disease affects a significant number of people, creating a serious health issue. The demand for coronary stents is anticipated to rise as the population ages and risk factors like obesity and diabetes become more common. The market is segmented by type and by gender. Some key players in this market include Renishaw, LivaNova, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
South Africa Nutritional Supplements Market Analysis
By 2030, it is anticipated that the South Africa Nutritional and Supplements market will reach a value of $xx Bn from $2.48 Bn in 2022, growing at a CAGR of xx% during 2022-2030. The nutritional supplements market in South Africa is primarily dominated by local players such as Solal Technologies Aspen Pharmacare and Adcock Ingram. The market for nutrition and supplements in South Africa is primarily driven by an inclination towards better health infrastructure, government regulations and increasing consumer awareness of health and lifestyle. The South Africa nutrition and supplements market in South Africa is segmented by Type, Product, application, and Distribution Channel.
UK Contraceptive Devices Market Analysis
UK's Contraceptive Devices Market is expected to witness growth from $335 Mn in 2022 to $535 Mn in 2030 with a CAGR of 6.00% for the forecasted year 2022-30. In the UK, people are becoming more aware of and accepting of contraceptive methods. Individuals are more likely to utilize contraceptives to avoid unwanted pregnancies as they become more aware of their alternatives. The market is segmented by type and by gender. Some key players in this market include Consilient Health, Renovos Biologics, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
UK Cardiovascular Diseases Therapeutics Market Analysis
UK's cardiovascular disease therapeutics market is projected to grow from $4.22 Bn in 2022 to $6.35 Bn in 2030 with a CAGR of 5.22% for the year 2022-30. Cardiovascular disease remains the major cause of death in the UK, also the development of new drugs for the treatment of cardiovascular diseases in the UK is the major growth driver of the market. The UK cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end user. Ackerley Pharma, eXmoor Pharma, and Bristol-Myers Squibb are the major players in the UK cardiovascular disease therapeutics market.
China Alcohol Addiction Therapeutics Market Analysis
The China Alcohol Addiction Therapeutics Market is valued at around $58 Mn in 2022 and is projected to reach $105 Mn by 2030, exhibiting a CAGR of 7.8% during the forecast period. The primary growth drivers in the China Alcohol Addiction Therapeutic Market are the escalating prevalence of Alcohol Addiction due to rising disposable income and sociocultural shifts, expanding treatment options, and government initiatives recognizing AUD as a public health concern. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in China are Merck & Co., Alkermes, TEVA, Otsuka Pharmaceuticals, Adial Pharmaceuticals, Yabao Pharmaceutical, Tasly Pharmaceutical, China Meheco Corporation, Tonghua Dongbao, Harbin Pharm etc.
Canada Alcohol Addiction Therapeutics Market Analysis
The Canada Alcohol Addiction Therapeutics Market is valued at around $57 Mn in 2022 and is projected to reach $93 Mn by 2030, exhibiting a CAGR of 6.3% during the forecast period. The Increasing public awareness, government support, and advancements in research and innovation are driving the destigmatization of alcohol addiction, fostering greater acceptance of mental health, and fueling the demand for more accessible and personalized treatment options, thus increasing market growth. The key players involved in the research, development, and distribution of alcohol addiction therapeutics in Canada are AbbVie, AstraZeneca, Roche, Bausch Health, Pfizer, Otsuka, Alkermes, Ethypharm, Biovail, Beacon etc among others.
Brazil Alcohol Addiction Therapeutics Market Analysis
The Brazil Alcohol Addiction Therapeutics Market is valued at around $18 Mn in 2022 and is projected to reach $31 Mn by 2030, exhibiting a CAGR of 7.3% during the forecast period. The intensified commitment of the Brazilian government to mental health, coupled with the urbanization-induced surge in alcohol consumption, is fuelling a rising need for treatment solutions. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Brazil are Alkermes, TEVA, Otsuka, GlaxoSmithKline, BioCorRx, Adial Pharmaceuticals, Kinnov Therapeutics, Opiant, MediciNova, Corcept Therapeutics, among others
Spain Age-Related Macular Degeneration Therapeutics Market Analysis
The Spain Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $208 Mn in 2022 and is predicted to grow at a CAGR of 7.90% from 2023 to 2030, to US $383 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, advancements in treatment, and other factors. Major players in the industry include Regeneron Pharmaceuticals, Novartis, Bayer, Roche, Genentech, and other notable companies
Kenya Cardiovascular Drugs Market Analysis
Kenya Cardiovascular Drug Market is at around $0.1 Bn in 2022 and is projected to reach $1.4 Bn in 2030, exhibiting a CAGR of 4.9% during the forecast period. Increased burden of cardiovascular diseases, government support & policies, and increased public awareness are driving the growth of the market. The market is dominated by key players like Regal Pharmaceuticals (KEN), Transwide Pharmaceuticals (KEN), Bristol-Myers Squibb Co., F. Hoffman-La Roche, Pfizer Inc., Astra Zeneca, Merck & Co., Sanofi, Novartis, and GSK.
Mexico Cardiovascular Drugs Market Analysis
Mexico Cardiovascular Drug Market is at around $2.1 Bn in 2022 and is projected to reach $2.9 Bn in 2030, exhibiting a CAGR of 4.05% during the forecast period. Increased prevalence of disease, greater awareness, and strategic partnerships between pharmaceutical companies and healthcare providers are driving the market. The market is dominated by key players like Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca, Sanofi, Novartis AG, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffman-La Roche Ltd.